Lexaria Bioscience Corp (LEXXW) support and resistance · rev $705.9K
Lexaria Bioscience Corp (LEXXW) common stock listed on US.
This page maps Lexaria Bioscience Corp (LEXXW) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported LEXXW revenue for 2025-08-31 was $705.9K. Net income was -$11.9M. Revenue was up 52.0% from 2024-08-31 to 2025-08-31. LEXXW currently screens at market cap $33.8M.
LEXXW currently screens at market cap $33.8M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new LEXXW 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the LEXXW quote page for the session range and the stock page for the full model.
Not investment advice.